|
|
 |
|
Viewing report
|
|
|
|
Company Financials: Pain Therapeutics, Inc.
Datamonitor, Jan 2010
The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .
Scope
- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation
- Provides key ratios
- Includes information on revenue distribution by business segments and geographies
Highlights of this title
Pain Therapeutics is a biopharmaceutical company that develops novel drugs. The company's lead drug candidate is Remoxy, an abuse-resistant painkiller. Its other three drug candidates in clinical programs include a novel radio-labeled monoclonal antibody to treat metastatic melanoma, PTI-202 and PTI-721.
Key reasons to purchase this title
- Includes information on revenue distribution by business segments and geographies
- Understand the financial evolution of the company over the last five years
- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization
Customers who bought this item also bought
Company Financials: Allos Therapeutics, Inc.
Company Financials: Acadia Pharmaceuticals Inc.
Company Financials: Medivation
Company Financials: MDRNA, Inc.
Company Financials: Cephalon, Inc
Company Financials: POZEN, Inc.
Company Financials: Adolor Corporation
Company Financials: Alexza Pharmaceuticals
Company Financials: Momenta Pharmaceuticals
Company Financials: Cypress Bioscience, Inc.
|
|
|
|
